HERMES' long term goal is to develop new and innovative molecularly targeted nanocarrier systems for therapeutic and other medical applications. These technologies are developed and brought to the market by HERMES independently, as well as with commercial partners through licensing of the core technology for specific applications and/or other strategic collaborations for late stage development.